Skip to content
Dr. Grey AI

Condition

Type 1 Diabetes

Type 1 diabetes is an autoimmune condition in which the immune system destroys the pancreas cells that make insulin, so blood sugar climbs. For blood glucose, trials of saffron and magnesium found improvements, though the evidence is moderate for saffron and limited for magnesium. Studies were small, and some included people with type 2 diabetes, so insulin remains essential and these results are a rough guide.

Sources: PMID 39818282; PMID 34836329

Supplements studied
17
Medicines and peptides
1
Graded outcomes
15
Trials
22
People studied
8,316

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

17 supplements

Saffron: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect6 studies840 people
Blood PressureImproves (the measure goes down)3 studies840 people
Liver EnzymesChanges; see studies1 study840 people
Blood Urea Nitrogen (BUN)Improves (the measure goes up)840 people
Kidney FunctionImproves (the measure goes up)840 people
Fiber: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Glycemic Control

Small Improvement

Improves (the measure goes up)Small effect64 people
HbA1cImproves (the measure goes down)1 study87 people

Beta-Alanine

  • Beta-cell function: worsens
  • Blood glucose: changes; see studies
  • HbA1c: changes; see studies
Beta-Alanine: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Beta-cell function

Small Decrease

Worsens (the measure goes down)Small effect82 people
Blood glucoseChanges; see studies1 study172 people
HbA1cChanges; see studies134 people
InsulinChanges; see studies82 people
Insulin ResistanceChanges; see studies82 people

Magnesium

  • Blood glucose: improves
  • Blood Pressure: improves
  • Triglycerides: improves
Magnesium: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect17 studies79 people
Blood PressureImproves (the measure goes down)10 studies79 people
TriglyceridesImproves (the measure goes down)2 studies79 people
Diabetic Neuropathy SymptomsImproves (the measure goes down)1 study97 people
LDL OxidationImproves (the measure goes down)1 study11 people
HbA1cImproves (the measure goes down)79 people
High-density lipoprotein (HDL)Improves (the measure goes up)79 people
WeightImproves (the measure goes down)79 people

Chromium

  • Blood glucose: improves
  • Weight: improves
  • Glycemic Control: improves
Chromium: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect6 studies40 people
WeightImproves (the measure goes down)12 studies40 people
Glycemic ControlImproves (the measure goes up)9 studies40 people
InsulinChanges; see studies1 study40 people

Studies that measured insulin

Total cholesterolImproves (the measure goes down)1 study40 people
TriglyceridesImproves (the measure goes down)40 people

L-Carnitine

  • Blood glucose: improves
  • Diabetic Neuropathy Symptoms: improves
  • HbA1c: improves
L-Carnitine: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect5 studies232 people
Diabetic Neuropathy SymptomsImproves (the measure goes down)1 study232 people
HbA1cImproves (the measure goes down)1 study232 people

Coenzyme Q10

  • Blood glucose: improves
  • Blood Pressure: improves
  • Low-density lipoprotein (LDL): improves
Coenzyme Q10: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect3 studies165 people
Blood PressureImproves (the measure goes down)4 studies105 people
Low-density lipoprotein (LDL)Improves (the measure goes down)4 studies165 people
Fatigue SymptomsImproves (the measure goes down)3 studies105 people
HbA1cImproves (the measure goes down)2 studies60 people
Total cholesterolImproves (the measure goes down)2 studies165 people
High-density lipoprotein (HDL)Improves (the measure goes up)1 study165 people
CrampsImproves (the measure goes down)105 people
Creatine KinaseChanges; see studies105 people
Glycemic ControlImproves (the measure goes up)60 people
InsulinChanges; see studies60 people
Kidney FunctionImproves (the measure goes up)105 people
Liver EnzymesChanges; see studies105 people
TriglyceridesImproves (the measure goes down)165 people
UreaImproves (the measure goes up)105 people
vLDL-CImproves (the measure goes down)60 people

Vitamin E

  • Blood Flow
  • LDL Oxidation: improves
Vitamin E: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood Flow

Mixed effect

2 studies41 people
LDL OxidationImproves (the measure goes down)41 people

Zinc

  • Blood glucose: improves
  • HbA1c: improves
  • Insulin: changes; see studies
Zinc: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucose

Small Improvement

Improves (the measure goes down)Small effect10 people
HbA1cImproves (the measure goes down)1 study10 people
InsulinChanges; see studies1 study10 people
Insulin ResistanceImproves (the measure goes down)10 people

Taurine

  • Blood Flow: improves
  • Blood Pressure: improves
  • Heart Rate: improves
Taurine: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood Flow

Moderate Increase

Improves (the measure goes up)Moderate effect19 people
Blood PressureImproves (the measure goes down)3 studies19 people
Heart RateImproves (the measure goes down)19 people

Vitamin C

  • Aerobic Exercise Metrics
  • HbA1c: improves
  • Oxidative Stress Biomarkers: improves
Vitamin C: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Aerobic Exercise Metrics

No effect

NoneNo effect2 studies26 people

Studies that measured aerobic exercise metrics

HbA1cImproves (the measure goes down)9 studies74 people
Oxidative Stress BiomarkersImproves (the measure goes down)5 studies26 people
TriglyceridesImproves (the measure goes down)5 studies50 people
Blood glucoseImproves (the measure goes down)3 studies100 people
Total cholesterolImproves (the measure goes down)2 studies50 people
Heart RateImproves (the measure goes down)1 study26 people
Plasma Vitamin CImproves (the measure goes up)1 study76 people
Blood PressureImproves (the measure goes down)24 people
Kidney FunctionImproves (the measure goes up)24 people

Fish Oil

  • C-Peptide
  • HbA1c: improves
Fish Oil: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
C-Peptide

No effect

NoneNo effect1 study90 people
HbA1cImproves (the measure goes down)2 studies90 people

Benfotiamine

  • HbA1c
  • High-density lipoprotein (HDL)
  • Nerve Repair: improves
Benfotiamine: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
HbA1c

No effect

NoneNo effect67 people
High-density lipoprotein (HDL)

No effect

NoneNo effect67 people
Nerve RepairImproves (the measure goes up)1 study67 people
InflammationChanges; see studies67 people
Total cholesterolChanges; see studies67 people

Vitamin D

  • Type 1 Diabetes Incidence: changes; see studies
Vitamin D: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Type 1 Diabetes IncidenceChanges; see studies1 study51 people

D-Ribose

  • Blood glucose: improves
D-Ribose: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Blood glucoseImproves (the measure goes down)1 study34 people

Resveratrol

  • Glycemic Control: improves
Resveratrol: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Glycemic ControlImproves (the measure goes up)1 study10 people

Bromelain

  • Type 1 Diabetes Incidence: changes; see studies
Bromelain: outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
Type 1 Diabetes IncidenceChanges; see studies1 study20 people

Prescription medicines and peptides studied, for context

These are not supplements. Most need a prescription, and some are research compounds with no approved use. They are listed so the supplement evidence above can be read against them.

1 medicine or peptide

Pramlintide (Symlin)

  • HbA1c Reduction (Type 1): improves
Pramlintide (Symlin): outcomes studied for Type 1 Diabetes
GradeOutcomeEffectSizeStudiesPeopleStudies list
HbA1c Reduction (Type 1)

FDA-approved for type 1 diabetes. Long-term studies show HbA1c and weight reduction without increased severe hypoglycemia.

Improves (the measure goes down)Moderate effect28 studies

Key findings

  • Blood glucoseSaffronImproves (the measure goes down)
  • Glycemic ControlFiberImproves (the measure goes up)
  • Beta-cell functionBeta-AlanineWorsens (the measure goes down)

The Type 1 Diabetes (Supportive Care) protocol

2 primary supplements · 2 supporting supplements

See the full protocol

Shop the evidence-backed picks

Support alongside medical care. These supplements are not a treatment for Type 1 Diabetes. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.

Fullscript collectionMetabolic health: evidence-graded picksOpen on Fullscript

Or shop one supplement

The supplements graded A or B for Type 1 Diabetes. Each opens third-party tested products for that supplement.

  • Grade B
  • Grade B
  • Grade B

We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure

Studies cited

2 studies from PubMed

  1. Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trialDiabetes Obes Metab · PMID 28345762
  2. A one-week reduced-carbohydrate diet to mitigate iatrogenic peripheral hyperinsulinemia does not improve insulin sensitivity or endothelial function in a randomized, crossover trial in patients with type 1 diabetes.Cardiovasc Diabetol · PMID 40045281